Incipiam Pharma
Early-stage pharmaceutical company focused on developing therapeutics that target energy expenditure as a complementary approach to existing metabolic disease treatments. Public materials describe a strategic focus on obesity and diabetes and indicate active R&D toward novel therapeutic approaches.
Industries
biotechnology
health-care
medical
Nr. of Employees
small (1-50)
Products
Therapeutics Targeting Energy Expenditure
Develops treatments for metabolic diseases by focusing on increasing energy expenditure rather than reducing energy intake.
Therapeutics Targeting Energy Expenditure
Develops treatments for metabolic diseases by focusing on increasing energy expenditure rather than reducing energy intake.
Services
Research and development of novel therapeutics focused on modulating energy expenditure to treat metabolic diseases.
Research and development of novel therapeutics focused on modulating energy expenditure to treat metabolic diseases.
Expertise Areas
- Metabolic disease therapeutics development
- Energy expenditure modulation
- Obesity and diabetes treatment strategy
- Early-stage drug discovery
Key Technologies
- Energy-expenditure modulation approaches
- Preclinical drug discovery methods
News & Updates
Default initial blog post present on the site (WordPress placeholder post).
Default initial blog post present on the site (WordPress placeholder post).